Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia
November 14, 2019 09:00 ET | Everest Medicines
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical...
Everest Medicines擴充高級領導團隊
September 16, 2019 08:14 ET | Everest Medicines
Jason Brown博士擔任業務主管Frank Grams博士擔任聯盟管理高級副總裁兼歐洲業務發展主管Sophia Zhu擔任投資組合發展及策略規劃高級副總裁Alex Wang擔任國際業務主管Daniel Weng擔任財務副總裁 上海及紐約, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Everest Medicines今天宣佈委任Everest...
Everest Medicines Expands Senior Leadership Team
September 16, 2019 06:00 ET | Everest Medicines
Dr. Jason Brown becomes Chief Business OfficerDr. Frank Grams as Senior Vice President of Alliance Management and Head of Business Development in EuropeSophia Zhu as Senior Vice President of Portfolio...